Altimmune's webcast to discuss these results and business updates will be held on May 13, 2025, at 8:30 a.m. ET. The market ...

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live ...

Q1 2025 Earnings Call Transcript May 10, 2025 Operator: Greetings, and welcome to the Zevia PBC First Quarter 2025 Earnings ...

LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...

First Quarter 2025 Financial and Operating Results: ...

Cash, cash equivalents, marketable securities and restricted cash as of April 30, 2025 totaled approximately $518 million. Announced up to $600 million non-dilutive ...

Good afternoon, everyone and thank you for joining our conference call to discuss BioStem Technologies' first quarter 2025 financial results and corporate highlights. Leading the call today will be ...

CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...

As of March 31, 2025, cash, cash equivalents and short-term investments totaled $87.3 million, compared to $100.1 million as of December 31, 2024. Cash flow from operations during the quarter was ...

Fox’s strategy differs from its biggest traditional media peers, and its business has been far more resilient as a result. Although it has outperformed in the past few years, we think its dependence ...

FDA hurdles, capital raises if share price pops. Treat as a lotto ticket: less than 1% of portfolio in common shares—small ...

Operating and Financial ResultsAxiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for ...